Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1/2, Open-label Study of PD-1 Knockout Tumor-infiltrating Lymphocytes (IOV-4001) in Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced no…

Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more

Iovance Biotherapeutics, Inc.NCT05361174